Daniel Martin Watterson

7PUBLICATIONS
18CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMedical devicesNeurology and neuromuscular diseasesCentral nervous systemEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2026
Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction.

|Feb 12, 2026
The Highly Selective 5-HT2B Receptor Antagonist MW073 Mitigates Aggressive Behavior in an Alzheimer's Disease Mouse Model.

Erica Acquarone, Saktimayee M Roy, Agnieszka Staniszewski

|Sep 09, 2025
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy.

Maria J Carlini, Jorge Espinoza-Derout, Meaghan Van Alstyne

|Mar 28, 2025
Optimized 5-HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction.

Saktimayee M Roy, Erica Acquarone, Elentina K Argyrousi

|Apr 13, 2019
A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction.

Saktimayee M Roy, George Minasov, Ottavio Arancio

|Apr 24, 2015
Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment.

Scott J Webster, Linda J Van Eldik, D Martin Watterson

Pageof 2

Frequent Collaborators

3 joint publications

Ottavio Arancio

3 joint publications

Saktimayee Mitra Roy

2 joint publications

Wayne F Anderson

1 joint publications

Jeffrey C Pelletier